Search by Drug Name or NDC
NDC 43063-0086-06 Famotidine 20 mg/1 Details
Famotidine 20 mg/1
Famotidine is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is FAMOTIDINE.
MedlinePlus Drug Summary
Prescription famotidine is used to treat ulcers (sores on the lining of the stomach or small intestine); gastroesophageal reflux disease (GERD, a condition in which backward flow of acid from the stomach causes heartburn and injury of the esophagus [tube that connects the mouth and stomach]); and conditions where the stomach produces too much acid, such as Zollinger-Ellison syndrome (tumors in the pancreas or small intestine that cause increased production of stomach acid). Over-the-counter famotidine is used to prevent and treat heartburn due to acid indigestion and sour stomach caused by eating or drinking certain foods or drinks. Famotidine is in a class of medications called H2 blockers. It works by decreasing the amount of acid made in the stomach.
Related Packages: 43063-0086-06Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Famotidine
Product Information
| NDC | 43063-0086 |
|---|---|
| Product ID | 43063-086_0644012f-55b5-2d87-e063-6394a90aa1c6 |
| Associated GPIs | 49200030000320 |
| GCN Sequence Number | 011677 |
| GCN Sequence Number Description | famotidine TABLET 20 MG ORAL |
| HIC3 | Z2D |
| HIC3 Description | HISTAMINE H2-RECEPTOR INHIBITORS |
| GCN | 46430 |
| HICL Sequence Number | 004521 |
| HICL Sequence Number Description | FAMOTIDINE |
| Brand/Generic | Generic |
| Proprietary Name | Famotidine |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Famotidine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/1 |
| Substance Name | FAMOTIDINE |
| Labeler Name | PD-Rx Pharmaceuticals, Inc. |
| Pharmaceutical Class | Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075511 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43063-0086-06 (43063008606)
| NDC Package Code | 43063-086-06 |
|---|---|
| Billing NDC | 43063008606 |
| Package | 6 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-086-06) |
| Marketing Start Date | 2011-02-11 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |